Urachal Adenocarcinoma
2 clinical trials · Condition
◉ Watch Urachal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology (NCT05756569) | Emory University | 2023-09-26 |
| Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors (NCT03866382) | National Cancer Institute (NCI) | 2019-05-13 |
Track Urachal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.